Literature DB >> 21623540

Synthesis and anti-HIV evaluation of 3'-triazolo nucleosides.

Vincent Roy1, Aleksandr Obikhod, Hong-Wang Zhang, Steven J Coats, Brian D Herman, Nicolas Sluis-Cremer, Luigi A Agrofoglio, Raymond F Schinazi.   

Abstract

A series of hitherto unknown 3'-α-[1,2,3]-substituted triazolo-2',3'-dideoxypyrimidine nucleoside analogues of the anti-HIV 3'-azido-3'-deoxythymidine (AZT) were synthesized through catalyzed alkyne-azide 1,3-dipolar cycloaddition (Huisgen reaction). Those 3'-[1,2,3]-triazolo analogues bearing an azido alkyl chain were evaluated for their anti-HIV activity against HIV-1 in primary human lymphocytes as well as for their cytotoxicity in different cells. None of them inhibit HIV replication (EC(50) > 20 μM); two of them were converted to their triphosphate form to evaluate their HIV-RT inhibition.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21623540     DOI: 10.1080/15257770.2011.580291

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  3 in total

1.  Clicking 3'-azidothymidine into novel potent inhibitors of human immunodeficiency virus.

Authors:  Venkata Ramana Sirivolu; Sanjeev Kumar V Vernekar; Tatiana Ilina; Nataliya S Myshakina; Michael A Parniak; Zhengqiang Wang
Journal:  J Med Chem       Date:  2013-10-28       Impact factor: 7.446

2.  Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1.

Authors:  Daniel Machado de Alencar; Juliana Gonçalves; Andreia Vieira; Sofia A Cerqueira; Cruz Sebastião; Maria Inês P S Leitão; Giulia Francescato; Paola Antenori; Helena Soares; Ana Petronilho
Journal:  Molecules       Date:  2021-11-06       Impact factor: 4.411

Review 3.  Chemical architecture and applications of nucleic acid derivatives containing 1,2,3-triazole functionalities synthesized via click chemistry.

Authors:  Tim Efthymiou; Wei Gong; Jean-Paul Desaulniers
Journal:  Molecules       Date:  2012-10-26       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.